Skip header and navigation

Refine By

5 records – page 1 of 1.

Consumption of added fats and oils in the European Prospective Investigation into Cancer and Nutrition (EPIC) centres across 10 European countries as assessed by 24-hour dietary recalls.

https://arctichealth.org/en/permalink/ahliterature18552
Source
Public Health Nutr. 2002 Dec;5(6B):1227-42
Publication Type
Article
Date
Dec-2002
Author
J. Linseisen
E. Bergström
L. Gafá
C A González
A. Thiébaut
A. Trichopoulou
R. Tumino
C. Navarro Sánchez
C. Martínez Garcia
I. Mattisson
S. Nilsson
A. Welch
E A Spencer
K. Overvad
A. Tjønneland
F. Clavel-Chapelon
E. Kesse
A B Miller
M. Schulz
K. Botsi
A. Naska
S. Sieri
C. Sacerdote
M C Ocké
P H M Peeters
G. Skeie
D. Engeset
U R Charrondière
N. Slimani
Author Affiliation
Unit of Human Nutrition and Cancer Prevention, Technical University of Munich, Alte Akademie 16, D-85350 Freising-Weihenstephan, Germany. j.linseisen@wzw.tum.de
Source
Public Health Nutr. 2002 Dec;5(6B):1227-42
Date
Dec-2002
Language
English
Publication Type
Article
Keywords
Adult
Aged
Diet Surveys
Dietary Fats - administration & dosage - adverse effects
Educational Status
Energy intake
Europe
Female
Humans
Male
Mental Recall
Middle Aged
Neoplasms - etiology
Population Surveillance - methods
Prospective Studies
Research Support, Non-U.S. Gov't
Abstract
OBJECTIVE: To evaluate the consumption of added fats and oils across the European centres and countries participating in the European Prospective Investigation into Cancer and Nutrition (EPIC). DESIGN AND SETTING: 24-Hour dietary recalls were collected by means of standardised computer-guided interviews in 27 redefined EPIC centres across 10 European countries. SUBJECTS: From an initial number of 36 900 subjects, single dietary recalls from 22 924 women and 13 031 men in the age range of 35-74 years were included. RESULTS: Mean daily intake of added fats and oils varied between 16.2 g (Varese, Italy) and 41.1 g (Malmö, Sweden) in women and between 24.7 g (Ragusa, Italy) and 66.0 g (Potsdam, Germany) in men. Total mean lipid intake by consumption of added fats and oils, including those used for sauce preparation, ranged between 18.3 (Norway) and 37.2 g day-1 (Greece) in women and 28.4 (Heidelberg, Germany) and 51.2 g day-1 (Greece) in men. The Mediterranean EPIC centres with high olive oil consumption combined with low animal fat intake contrasted with the central and northern European centres where fewer vegetable oils, more animal fats and a high proportion of margarine were consumed. The consumption of added fats and oils of animal origin was highest in the German EPIC centres, followed by the French. The contribution of added fats and oils to total energy intake ranged from 8% in Norway to 22% in Greece. CONCLUSIONS: The results demonstrate a high variation in dietary intake of added fats and oils in EPIC, providing a good opportunity to elucidate the role of dietary fats in cancer aetiology.
PubMed ID
12639229 View in PubMed
Less detail

Consumption of dairy products in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort: data from 35 955 24-hour dietary recalls in 10 European countries.

https://arctichealth.org/en/permalink/ahliterature18551
Source
Public Health Nutr. 2002 Dec;5(6B):1259-71
Publication Type
Article
Date
Dec-2002
Author
A. Hjartåker
A. Lagiou
N. Slimani
E. Lund
M D Chirlaque
E. Vasilopoulou
X. Zavitsanos
F. Berrino
C. Sacerdote
M C Ocké
P H M Peeters
D. Engeset
G. Skeie
A. Aller
P. Amiano
G. Berglund
S. Nilsson
A. McTaggart
E A Spencer
K. Overvad
A. Tjønneland
F. Clavel-Chapelon
J. Linseisen
M. Schulz
B. Hemon
E. Riboli
Author Affiliation
Section of Medical Statistics, University of Oslo, PO Box 1122, Blindern, N-0317 Norway. anette.hjartaker@basalmed.uio.no
Source
Public Health Nutr. 2002 Dec;5(6B):1259-71
Date
Dec-2002
Language
English
Publication Type
Article
Keywords
Adult
Aged
Dairy Products
Diet
Diet Surveys
Europe
Female
Humans
Male
Mental Recall
Middle Aged
Population Surveillance - methods
Prospective Studies
Research Support, Non-U.S. Gov't
Abstract
OBJECTIVES: To describe and compare the consumption of dairy products in cohorts included in the European Prospective Investigation into Cancer and Nutrition (EPIC). METHODS: Data from single 24-hour dietary recall interviews collected through a highly standardised computer-based program (EPIC-SOFT) in 27 redefined centres in 10 European countries between 1995 and 2000. From a total random sample of 36 900, 22 924 women and 13 031 men were selected after exclusion of subjects under 35 and over 74 years of age. RESULTS: A high total consumption of dairy products was reported in most of the centres in Spain and in the UK cohort sampled from the general population, as well as in the Dutch, Swedish and Danish centres. A somewhat low consumption was reported in the Greek centre and in some of the Italian centres (Ragusa and Turin). In all centres and for both sexes, milk constituted the dairy sub-group with the largest proportion (in grams) of total dairy consumption, followed by yoghurt and other fermented milk products, and cheese. Still, there was a wide range in the contributions of the different dairy sub-groups between centres. The Spanish and Nordic centres generally reported a high consumption of milk, the Swedish and Dutch centres reported a high consumption of yoghurt and other fermented milk products, whereas the highest consumption of cheese was reported in the French centres. CONCLUSION: The results demonstrate both quantitative and qualitative disparities in dairy product consumption among the EPIC centres. This offers a sound starting point for analyses of associations between dairy intake and chronic diseases such as cancer.
PubMed ID
12639231 View in PubMed
Less detail

Demographic, symptom, and medication profiles of cancer patients seen by a palliative care consult team in a tertiary referral hospital.

https://arctichealth.org/en/permalink/ahliterature198939
Source
J Pain Symptom Manage. 2000 Mar;19(3):174-84
Publication Type
Article
Date
Mar-2000
Author
C A Jenkins
M. Schulz
J. Hanson
E. Bruera
Author Affiliation
Division of Palliative Medicine, University of Alberta, Edmonton, Alberta, Canada.
Source
J Pain Symptom Manage. 2000 Mar;19(3):174-84
Date
Mar-2000
Language
English
Publication Type
Article
Keywords
Adult
Aged
Aged, 80 and over
Alberta - epidemiology
Analgesics, Opioid - therapeutic use
Drug Therapy
Female
Humans
Male
Middle Aged
Neoplasms - epidemiology - therapy
Palliative Care
Referral and Consultation
Retrospective Studies
Socioeconomic Factors
Abstract
In this retrospective study, the charts of 100 consecutive cancer patients who had been referred to a palliative care consult team within a tertiary acute care hospital were reviewed. Demographic characteristics, including reason for admission and disease status upon admission, length of stay, and discharge and admission location, were recorded. Symptom acuity, cognitive status, and risk for substance abuse were evaluated. Medications before and after the consult were tabulated and compared to recommended medications; compliance with the recommendations was assessed. Five patients were not palliative at the time of the consult. Only 46/95 (48%) were known to have untreatable cancer at the time of their admission. The CAGE questionnaire for alcoholism and the Mini-Mental State Questionnaire (MMSQ) were abnormal in 19/78 (24%) and 40/91 (44%), respectively. The most intense symptoms, as measured by the 100-mm scales of the Edmonton Symptom Assessment Scale (ESAS) were fatigue (72 +/- 24), appetite (60 +/- 32), and well-being (50 +/- 29). Eighty-nine of the 95 patients were living at home prior to admission and 34/95 were able to return home. Twenty died during hospitalization, 23 were transferred to a palliative care unit, and the remaining 18 were discharged to another hospital or long-term care. The patient's physician complied with the palliative care consult team's recommendation in 122/137 cases (89%).
PubMed ID
10760622 View in PubMed
Less detail

NIPPV: prevalence, approach and barriers to use at Canadian ALS centres.

https://arctichealth.org/en/permalink/ahliterature145313
Source
Can J Neurol Sci. 2010 Jan;37(1):54-60
Publication Type
Article
Date
Jan-2010
Author
Benjamin R Ritsma
Michael J Berger
David A Charland
Michael A Khoury
Joel T Phillips
Michael J Quon
Michael J Strong
Valerie M Schulz
Author Affiliation
Schulich School of Medicine & Dentistry, The University of Western Ontario, London, Ontario, Canada.
Source
Can J Neurol Sci. 2010 Jan;37(1):54-60
Date
Jan-2010
Language
English
Publication Type
Article
Keywords
Amyotrophic Lateral Sclerosis - complications - epidemiology - therapy
Canada - epidemiology
Dyspnea - epidemiology - therapy
Hospitals - statistics & numerical data - utilization
Humans
Multicenter Studies as Topic
Physician's Practice Patterns - statistics & numerical data
Positive-Pressure Respiration - methods - statistics & numerical data
Prevalence
Quality of Health Care
Questionnaires
Respiratory Insufficiency - epidemiology - therapy
Single-Blind Method
Tracheostomy - methods
Abstract
The purpose of this study was to evaluate Canadian amyotrophic lateral sclerosis (ALS) centres with respect to: 1) the prevalence of Non-invasive positive pressure ventilation (NIPPV) and invasive mechanical ventilation via tracheostomy (TV) utilization, 2) the approach to NIPPV use, focusing upon the currently employed initiation criteria and 3) the barriers influencing NIPPV administration.
A descriptive survey research design aimed to obtain quantitative data and open-ended responses from an active physician at each of the 15 multidisciplinary Canadian ALS centres.
The principal findings of this study were: 1) NIPPV and TV are used in 18.3% and 1.5% of patients at Canadian ALS centres, respectively, 2) symptoms of respiratory insufficiency, namely orthopnea (clinical significance rated at 9.00/10 +/- 1.48), dyspnea (8.27 +/- 1.95) and morning headache (7.55 +/- 1.21) are the most significant indicators for NIPPV initiation, 3) the primary barriers to NIPPV utilization are patient intolerance (70% of centres) and inaccessibility of respirologists and ventilation technologists (50% of centres).
Variability in NIPPV use has an impact upon the management of Canadian ALS patients. The establishment of more definitive NIPPV initiation criteria, emphasizing respiratory symptoms, and the attenuation of barriers to NIPPV use should be targeted so as to ensure optimal care for all ALS patients.
Notes
Comment In: Can J Neurol Sci. 2010 Jan;37(1):320169767
PubMed ID
20169774 View in PubMed
Less detail